Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009–2020)
Dermatitis® · 2025
DOI: 10.1089/derm.2024.0118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatitis®, 2025. Verfasst von Erin M Warshaw und 15 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Park Nicollet/Health Partners Health Services, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Patch Tests, Dermatitis, Allergic Contact, Mentha piperita, Plant Oils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background
Mentha piperita (MP; peppermint) oil has many commercial uses.
Objective
To characterize the epidemiology of contact allergy to MP oil 2% petrolatum.
Methods
Retrospective analysis of North American Contact Dermatitis Group data (2009–2020).
Results
Of 28,128 patients tested to MP, 161 (0.6%) had an allergic reaction. Most allergic patients were female (77.0%) and/or over 40 years of age (71.4%). The most common anatomical sites of dermatitis included face (31.7%; of these, one-third specified lips), hands (17.4%), and scattered/generalized (18.6%). Nearly one-third (30.4%) of reactions were strong (++)/extreme (+++), and 80.1% were considered currently relevant. Common sources included oral hygiene preparations, foods, and lip products. Co-reaction with at least 1 of the other 19 fragrance/plant-related screening test preparations occurred in 82.6% (133/161) of MP-allergic patients, most commonly Cananga odorata oil (42.9%), fragrance mix I (41.0%), hydroperoxides of linalool (35.7%), Compositae mix (35.4%), Jasminum officinale oil (31.9%), Myroxylon pereirae (31.7%), and propolis (28.1%). Co-reaction with at least 1 of the 3 most commonly used fragrance screening allergens (fragrance mix I, fragrance mix II, and/or Myroxylon pereirae ) was 59.6%.
Conclusions
Twelve-year prevalence of MP allergy was 0.6%. Approximately 40% of cases would have been missed if only fragrance screening allergens were tested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Dermatology, Park Nicollet/Health Partners Health Services, Minneapolis, Minnesota, USA.
- Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
- Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.
- Department of Dermatology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
- Division of Dermatology, Sunnybrook Health Sciences Center, University of Toronto, Ontario, Canada.
- Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Erin M Warshaw, Malina Yamashita Peterson, Brandon L Adler, Donald V Belsito, Amber R Atwater, Jonathan I Silverberg
Zitieren
APA
Warshaw, E. M., Peterson, M. Y., DeKoven, J. G., Adler, B. L., Pratt, M. D., Belsito, D. V., Atwater, A. R., Houle, M. C., Dunnick, C. A., Yu, J., Taylor, J. S., Silverberg, J. I., Reeder, M. J., DeLeo, V. A., Mowad, C., & Botto, N. C. (2025). Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009–2020). Dermatitis®. https://doi.org/10.1089/derm.2024.0118
Vancouver
Warshaw EM, Peterson MY, DeKoven JG, Adler BL, Pratt MD, Belsito DV, et al. Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009–2020). Dermatitis®. 2025. doi:10.1089/derm.2024.0118
BibTeX
@article{Warshaw2025,
author = {Warshaw, Erin M and Peterson, Malina Yamashita and DeKoven, Joel G and Adler, Brandon L and Pratt, Melanie D and Belsito, Donald V and Atwater, Amber R and Houle, Marie-Claude and Dunnick, Cory A and Yu, Jiade and Taylor, James S and Silverberg, Jonathan I and Reeder, Margo J and DeLeo, Vincent A and Mowad, Christen and Botto, Nina C},
title = {Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009–2020)},
journal = {Dermatitis®},
year = {2025},
doi = {10.1089/derm.2024.0118}
}
EUVIMED